Seventure Partners Overview
- Investor Type
- Venture Capital
- Status
- Active
- Professionals
- 15
- Investments
- 321
- Portfolio
- 104
- Exits
- 123
Seventure Partners General Information
Description
Founded in 1997, Seventure Partners is a venture capital firm headquartered in Paris, France. The firm prefers to invest in the digital technologies, life sciences, and sports and wellbeing sectors.
Contact Information
Investor Status
Actively Seeking New Investments
Trade Association
Principles for Responsible Investment (PRI)
Primary Investor Type
Venture Capital
Other Investor Types
Growth/Expansion
Primary Office
- 5-7 rue de Monttessuy
- Cedex 07
- 75340 Paris
- France
+33 01 00 00 00 00
Seventure Partners Investments & Acquisitions (321)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| BCD Bioscience | 09-Nov-2020 | Early Stage VC | 00.000 | Biotechnology | Generating Revenue | 00000 000000000 |
| 0000000 | 09-Nov-2020 | 00000 00000 | 00.000 | Personal Products | Generating Revenue | 00000000 00 0000000 |
| 0000000000 000 | 06-Oct-2020 | 00000 00000 | 0000 | Drug Discovery | Startup | |
| 00000000 | 01-Oct-2020 | 00000 00000 | 00.000 | Drug Discovery | Generating Revenue | |
| 0000000 | 25-Sep-2020 | 00000 00000 | 0000 | Drug Discovery | Clinical Trials - General | |
| 000000 00000000000 | 22-Sep-2020 | 00000 00000 | 0000 | Drug Delivery | Clinical Trials - Phase 2 | 0000 00 00 00000000 00.0 |
| 00000 | 27-Jul-2020 | 00000 00000 | 00.000 | Clothing | Generating Revenue | 00000000 0000000000 |
| 0000000 | 21-Jul-2020 | 00000 00000 | 000.00 | Biotechnology | Generating Revenue | |
| LiMM Therapeutics | 15-Jul-2020 | Seed Round | 00.000 | Drug Delivery | Startup | 00000000 00 0000000 |
| Citryll | 02-Jul-2020 | Early Stage VC | 000.00 | Drug Discovery | Pre-Clinical Trials | 00000000 00 0000000 |
Seventure Partners Exits (121)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| Galecto | 29-Oct-2020 | IPO | 0000 |
| 000000 | 15-Jul-2020 | 000000000000000000 | |
| 000000000000 | 20-Jan-2020 | 00000000 000000 00 | |
| 000000 | 17-Dec-2019 | 000 00 00000000 | |
| 00000000000 | 30-Nov-2019 | 000000000000000000 | 00.000 |
| 000000 | 22-Oct-2019 | 000000000000000000 | |
| 0000000 | 22-Oct-2019 | 0000000000 | |
| 0000 00000 | 17-Sep-2019 | 000000000000000000 | |
| Chronotruck | 09-Jul-2019 | Merger/Acquisition | |
| EndoControl | 12-Jun-2019 | Merger/Acquisition |
Seventure Partners Investments by Industry, Year, and Region
Investments by Industry
Investments by Year
Investments by Region
PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.
Request a free trialSeventure Partners Team (43)
| Name | Title | Deals | Funds | Boards | Office |
|---|---|---|---|---|---|
| Isabelle de Cremoux | Chief Executive Officer and Managing Partner | 00 | 00 | 0 | Paris, France |
| Pierre Aumenier | Chief Financial Officer | Paris, France | |||
| Bruno Rivet | General Partner | 0 | 0 | 0 | Paris, France |
| Emmanuel Fiessinger | General Partner | 0 | 0 | Paris, France | |
| Eric de La Fortelle Ph.D | Venture Partner | 0 | 0 | 0 | Basel, Switzerland |
Seventure Partners Co-Investors (236)
| Name | With | Exits | Lead Partner | Series | Industry |
|---|---|---|---|---|---|
| Bpifrance | 7 | 0 | 0 |
|
|
| SymBiosis LLC | 0 | 0 |
|
|
|
| Bayern Kapital | 0 | 0 |
|
|
|
| Bristol-Myers Squibb | 0 | 0 | 0 |
|
|
| Johnson & Johnson Innovation - JJDC | 0 | 0 |
|
|